d12fc373af36e18ec1964aa4b18a9c27f8922591a91236667c15c474964aa986  ./LICENSE
9422d5b3371c9d4c4cb6698913f75d7afdd408b9d670527f31f1b21415b097f8  ./README.md
7d8c663c8a6e886ee95d3f7ee50ce36c7f121db7b2a223e90d4511db58f2407e  ./SEARCH_LOG.md
a0e0d4d53afd2245842000b2eb2e833730ea71cb1d1d1b0896ad65d4a3b333a9  ./data_derived/download_logs.json
b03fe60054d8f6450749bfeff2ee8aa1092c89262ea24984e05e9c571af43ebe  ./data_derived/sec_8k_item202_dates.csv
aa9b12a64262fff8f49e6721117ba4e06afd5d4364848c65c9801abd0f0c592c  ./results/figure1_placebo.png
6b895087795a88cd3a995fbee5e6379dab0288ea8e9328635f8f3d3c415c1d69  ./results/figure2_dollar_value_by_group.png
471dc62a988f02c3106b48c9d384e6c6a2c1fe95f88480af65a376c7af7190b5  ./results/figure3_concentration_curves.png
a5aa0b8eca9b06c2584a88a02e586b9210c998747dd796321db111f30a66d2cb  ./results/figure4_persistence.png
f022ea379162d9686fe4d0dae3390c17f0859a3c06a753f6a6a4ac5c34707882  ./results/firm_level_results.csv
38bad9efce66f79f74a612165d78de5ed6e3ab43372f896a09dfdcb0e89250ea  ./results/manuscript_tables.json
8c1d92d1befb1fd353e3c55c550448e140d2262487d46e7f8c6d5b858948d5cc  ./results/placebo_distribution.csv
891a241cecce3383856574632ced7decfc0170e1b052977f979b0324b7e19d90  ./results/results_summary.json
9cd698140019efc5bba3b11840f7865d3f175d4bca2be9a6b6756b1cf53fc8b9  ./results/table1_sample_coverage.csv
755fd9f2b36ad67502033e79920742283a1c0a6487ff72adbf45ada906a10317  ./results/table2_group_cars.csv
dd1f50fd7bd51f2aea2e4a2a5eeb5743a175266e4ac409c4ccc57c314993fc83  ./results/table3_sector_dollar_value.csv
50fbabdaf387fd2da77b1c4633b78f4aa8b172df0911d4a982e5d5798cc029da  ./results/table4_concentration.csv
598b7c3f910280a6c292d5fee6af463724f7c562e70a49922be774064b6af587  ./results/table5_top_gainers_losers.csv
0ac0c212f8968a2e9c7875c39e0872b6aff0ee80cd766e12ab9af24ccda842e9  ./results/table6_persistence.csv
30e8ce3ee337ee79b7a8905a05aba29866f4e163b257c3d2d8ecbb9259bb1be2  ./results/table7_ai_group_dollar_value.csv
e6af367a9b8ce259772483c04611e60e757d70f85b394ca364ad6756f501425d  ./results/tableR1_robustness_samples.csv
909a34106620cdc2e67c607cb97e46c4da15a1f5719e4278648395272c7a813e  ./results/tableR2_ai_group_dollar_value_full_sample.csv
b457f7ef8f78b23d2dd525f88832bf9d752243b3acff6eca5fa9bcdfb97aac2b  ./results/tableR3_extended_earnings_exclusion.csv
45f4f9f0c7221ce0122758cf677e0f65fd355c25fd1c0d2441f075abf5ad6b1f  ./scripts/01_download_data.py
2702d8b459ff3125046b9e46fc70ea14badadddf32ff352767b34031863f5a13  ./scripts/02_patch_data.py
5fd5e32c70f36a23c3c37c563358465c25146860f7dfb81d2ac399f3fed73c4e  ./scripts/02b_shares_splits.py
7ef567189c6ad54380584cd5e6e43cb2e5138834d6c32673fb3c5a4c2b62572e  ./scripts/02c_gics_shares.py
791a2609b095161cf3c3c82055f2dfe5ab52b53e66c490aca19d7f6a914fdf0e  ./scripts/02d_earnings_dates.py
eb12fc907ec4b337f8154897f1224ffb74b644a0d9bf774ff068783c3ce5cf25  ./scripts/03_analysis.py
7dd386b601ee7f708433fca3c91ec1d9d6eda6a0111ebeff78bc78e7b4fe093b  ./scripts/04_tables_for_manuscript.py
